Skip to main content

3 Result(s)

within Zoe June Assaf Remove this filter

and

  1. Article

    Open Access

    Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial

    Although comprehensive biomarker testing is recommended for all patients with advanced/metastatic non-small cell lung cancer (NSCLC) before initiation of first-line treatment, tissue availability can limit tes...

    Solange Peters, Shirish M. Gadgeel, Tony Mok, Ernest Nadal… in Nature Medicine (2024)

    Download PDF (4290 KB) View Article

  2. No Access

    Article

    ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

    Minimally invasive approaches to detect residual disease after surgery are needed to identify patients with cancer who are at risk for metastatic relapse. Circulating tumour DNA (ctDNA) holds promise as a biom...

    Thomas Powles, Zoe June Assaf, Nicole Davarpanah, Romain Banchereau… in Nature (2021)

  3. Article

    Open Access

    Molecular determinants of response to PD-L1 blockade across tumor types

    Immune checkpoint inhibitors targeting the PD-1/PD-L1 axis lead to durable clinical responses in subsets of cancer patients across multiple indications, including non-small cell lung cancer (NSCLC), urothelial...

    Romain Banchereau, Ning Leng, Oliver Zill, Ethan Sokol, Gengbo Liu… in Nature Communications (2021)

    Download PDF (3034 KB) View Article